Literature DB >> 7654888

Review article: quantitative tests of liver function.

R Jalan1, P C Hayes.   

Abstract

The search continues for a single reliable test of liver function that provides accurate prognostic information in chronic liver disease, in acute liver failure, and about graft function following orthotopic liver transplantation. Although transaminases, the commonly used markers of hepatocellular injury, have a high sensitivity in screening for liver disease, they do not provide any information about prognosis. Rational assessment of liver function using bilirubin, serum albumin and prothrombin-time is limited by the relative lack of sensitivity of these measurements and their inability to identify the functional reserve of the liver. Dynamic liver function tests are an improvement on the static tests but are generally cumbersome. The ideal liver function test would be cheap, easy to perform and analyse, safe, have a simple pharmacokinetic profile with minimal drug interactions, have a high predictive value and provide quick results. Numerous quantitative liver function tests have been developed and have shown promise in some studies. The aim of this review is to assess the place of these tests in the practical management of liver disease.

Entities:  

Mesh:

Year:  1995        PMID: 7654888     DOI: 10.1111/j.1365-2036.1995.tb00380.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  16 in total

1.  Oral or intravenous lidocaine administration to perform megx test?

Authors:  E Giannini; F Botta; P Romagnoli; R Testa
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

Review 2.  Protection of the liver during hepatic surgery.

Authors:  Pierre-Alain Clavien; Jean Emond; Jean Nicolas Vauthey; Jacques Belghiti; Ravi S Chari; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

Review 3.  Liver enzyme alteration: a guide for clinicians.

Authors:  Edoardo G Giannini; Roberto Testa; Vincenzo Savarino
Journal:  CMAJ       Date:  2005-02-01       Impact factor: 8.262

4.  Dynamic contrast-enhanced optical imaging of in vivo organ function.

Authors:  Cyrus B Amoozegar; Tracy Wang; Matthew B Bouchard; Addason F H McCaslin; William S Blaner; Richard M Levenson; Elizabeth M C Hillman
Journal:  J Biomed Opt       Date:  2012-09       Impact factor: 3.170

5.  MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.

Authors:  F Botta; E Giannini; P Romagnoli; A Fasoli; F Malfatti; B Chiarbonello; E Testa; D Risso; G Colla; R Testa
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

6.  Progressive liver functional impairment is associated with an increase in AST/ALT ratio.

Authors:  E Giannini; F Botta; A Fasoli; P Ceppa; D Risso; P B Lantieri; G Celle; R Testa
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

7.  Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels.

Authors:  D Festi; S Capodicasa; L Sandri; L Colaiocco-Ferrante; T Staniscia; E Vitacolonna; A Vestito; P Simoni; G Mazzella; P Portincasa; E Roda; A Colecchia
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

Review 8.  Effect of hepatic insufficiency on pharmacokinetics and drug dosing.

Authors:  R K Verbeeck; Y Horsmans
Journal:  Pharm World Sci       Date:  1998-10

9.  Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients.

Authors:  Edoardo Giannini; Alberto Fasoli; Federica Botta; Paola Romagnoli; Federica Malfatti; Bruno Chiarbonello; Mario Mamone; Vincenzo Savarino; Roberto Testa
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

10.  Relationship between 13C-aminopyrine breath test and the MELD score and its long-term prognostic use in patients with cirrhosis.

Authors:  Edoardo G Giannini; Vincenzo Savarino
Journal:  Dig Dis Sci       Date:  2013-07-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.